Your browser doesn't support javascript.
loading
A Randomized Trial Evaluating Patient Experience and Preference Between Octreotide Long-Acting Release and Lanreotide for Treatment of Well-Differentiated Neuroendocrine Tumors.
Raj, Nitya; Cruz, Elizabeth; O'Shaughnessy, Sarah; Calderon, Claudia; Chou, Joanne F; Capanu, Marinela; Heffernan, Olivia; DeMore, April; Punn, Sippy; Le, Tiffany; Hauser, Haley; Saltz, Leonard; Reidy-Lagunes, Diane.
Afiliação
  • Raj N; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Cruz E; Memorial Sloan Kettering Cancer Center, New York, NY.
  • O'Shaughnessy S; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Calderon C; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Chou JF; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Capanu M; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Heffernan O; Memorial Sloan Kettering Cancer Center, New York, NY.
  • DeMore A; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Punn S; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Le T; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hauser H; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Saltz L; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Reidy-Lagunes D; Memorial Sloan Kettering Cancer Center, New York, NY.
JCO Oncol Pract ; 18(9): e1533-e1541, 2022 09.
Article em En | MEDLINE | ID: mdl-35724357

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Octreotida / Tumores Neuroendócrinos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: JCO Oncol Pract Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Octreotida / Tumores Neuroendócrinos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: JCO Oncol Pract Ano de publicação: 2022 Tipo de documento: Article